Xynomic Dosed First Patient in Phase 1/2 Lymphoma Trial
June 06, 2019 12:30 ET
|
Xynomic Pharmaceuticals Holdings, Inc.
RALEIGH, N.C. and SHANGHAI, June 06, 2019 (GLOBE NEWSWIRE) -- Xynomic Pharmaceuticals Holdings, Inc. (“Xynomic”, Nasdaq: XYN), a clinical stage US-China oncology drug development company, announced...
Xynomic Pharma To Present Long-Term Follow Up Data Showing Abexinostat, Combined with Pazopanib, has Durable Responses in Patients with Pre-Treated Kidney Cancer
May 21, 2019 16:30 ET
|
Xynomic Pharmaceuticals Holdings, Inc.
RALEIGH, N.C. and SHANGHAI, May 21, 2019 (GLOBE NEWSWIRE) -- Xynomic Pharmaceuticals Holdings, Inc. (“Xynomic”), a clinical stage US-China oncology drug development company (Nasdaq: XYN), announced...
BISON CAPITAL ACQUISITION CORP. ANNOUNCES CLOSING OF ITS BUSINESS COMBINATION WITH XYNOMIC PHARMACEUTICALS, INC.
May 15, 2019 12:14 ET
|
Xynomic Pharmaceuticals Holdings, Inc.
New York, NY, May 15, 2019 (GLOBE NEWSWIRE) -- Bison Capital Acquisition Corp. (NASDAQ: BCAC) (“BCAC” or the “Company”) today announced that it has closed its business combination with Xynomic...
Bison Capital Acquisition Corp. Announces the Postponement of the Meeting Date for the Special Meeting of Shareholders to Approve Business Combination with Xynomic Pharmaceuticals, Inc.
May 03, 2019 16:45 ET
|
Bison Capital Acquisition Corp.
NEW YORK, NY and SHANGHAI, CHINA, May 03, 2019 (GLOBE NEWSWIRE) -- The special meeting (the “Special Meeting”) of shareholders of Bison Capital Acquisition Corp. (“BCAC”, NASDAQ: BCAC), originally...
Bison Capital Acquisition Corp. Announces Record and Meeting Dates for the Special Meeting of Shareholders to Approve Business Combination with Xynomic Pharmaceuticals, Inc.
April 29, 2019 15:34 ET
|
Bison Capital Acquisition Corp.
NEW YORK, NY and SHANGHAI, CHINA, April 29, 2019 (GLOBE NEWSWIRE) -- Bison Capital Acquisition Corp. (“BCAC”, NASDAQ: BCAC) announced today, that it has established a record date of April 5, 2019...
Bison Capital Acquisition Corp. Clarifies Information of Its Chairman and President
October 18, 2018 17:28 ET
|
Bison Capital Acquisition Corp.
NEW YORK, NY and SHANGHAI, China, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Bison Capital Acquisition Corp. (“BCAC”, NASDAQ: BCAC) today issued an announcement in order to clarify some information regarding...
Bison Capital Acquisition Corp. and Xynomic Pharmaceuticals, Inc. Announce Signing of Definitive Merger Agreement
September 12, 2018 21:50 ET
|
Bison Capital Acquisition Corp.
NEW YORK, NY and SHANGHAI, China, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Bison Capital Acquisition Corp. (“BCAC”, NASDAQ: BCAC) and Xynomic Pharmaceuticals, Inc. (“Xynomic”), a U.S.-China clinical stage...
Bison Capital Acquisition Corp. Ordinary Shares, Warrants and Rights to Commence Trading Separately on or About July 17, 2017
July 13, 2017 15:45 ET
|
Bison Capital Acquisition
NEW YORK and HONG KONG, July 13, 2017 (GLOBE NEWSWIRE) -- Bison Capital Acquisition Corp. (NASDAQ:BCACU) (the “Company” or “Bison”) announced today that the holders of the Company’s units may elect...
Bison Capital Acquisition Corp. Announces Consummation of Over-Allotment Exercise in Connection With Its Initial Public Offering
July 05, 2017 18:25 ET
|
Bison Capital Acquisition
NEW YORK and HONG KONG, July 05, 2017 (GLOBE NEWSWIRE) -- Bison Capital Acquisition Corp. (Nasdaq:BCACU) ("Bison" or the "Company"), announced today that the underwriters of its initial public...
Bison Capital Acquisition Corp. Completes $52,500,000 Initial Public Offering
June 23, 2017 18:12 ET
|
Bison Capital Acquisition
NEW YORK and HONG KONG, June 23, 2017 (GLOBE NEWSWIRE) -- Bison Capital Acquisition Corp. (Nasdaq:BCACU) ("Bison" or the "Company"), a company formed for the purpose of entering into a merger, share...